Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 31;12(8):1855.
doi: 10.3390/diagnostics12081855.

Strategic Significance of Low Viral Load of Human Papillomavirus in Uterine Cervical Cytology Specimens

Affiliations

Strategic Significance of Low Viral Load of Human Papillomavirus in Uterine Cervical Cytology Specimens

Nora Jee-Young Park et al. Diagnostics (Basel). .

Abstract

Infection with high-risk (HR) Human Papillomavirus (HPV) is associated with the development of precancerous lesions or invasive carcinoma of the uterine cervix. Thus, the high viral load (VL) of HR-HPV DNA currently serves as a representative quantitative marker for cervical cancer. However, the clinical significance of low HPV DNA VL remains undetermined. This study aimed to evaluate the clinical association between the low HPV DNA VL and cytology/histologic diagnosis of cervical samples. We searched the electronic medical databases for the resultant analyses of HPV genotyping among patients who underwent treatment for any cervical lesion or who had undergone gynecological examinations with any positive HPV results according to the national cancer screening service between 2015 and 2016. HPV testing with genotyping and semi-quantitative VL measurement was conducted using an AnyplexTM II H28 Detection assay (H28 assay, Seegene, Seoul, Republic of Korea). The H28 assay is a multiplex semi-quantitative real-time PCR test using the tagging of oligonucleotide cleavage and extension (TOCE) technology. The VL was semi-quantified as high (3+; positive signal before 31 PCR cycles), intermediate (2+; positive between 31 and 39 PCR cycles), or low (1+; positive after 40 PCR cycles). Out of 5940 HPV VL analyses, 356 assays (5.99%) were reported as low VL (1+) of HPV DNA. Matched cytology diagnoses were mostly negative findings (n = 347, 97.5%), except for seven cases of atypical squamous cells of undetermined significance (1.9%) and two cases of atypical glandular cells (0.6%). During the follow-up periods, abnormal cytologic diagnoses were identified, including one case of high-grade squamous intraepithelial lesion (HSIL) and two low-grade squamous intraepithelial lesions (LSILs). The matched, confirmative histologic diagnosis of HSIL cytology was compatible with chronic inflammation, wherein the two LSILs had regular check-ups. None revealed clinically concerned outcomes associated with HPV-related squamous lesions. The cytology was most likely negative for malignancy when the VL of HPV DNA was low (1+). Additional strategic monitoring and management may thus be unnecessary.

Keywords: HPV DNA; Human Papillomavirus; cervical cytology; shared decision making; viral load.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Flowchart of the sample selection and analysis process in this study.
Figure 2
Figure 2
Illustration for clinical follow-ups of low VL (1+) HPV test in this study.

Similar articles

References

    1. WHO Classification of Tumours Editorial Board . WHO Classification of Tumours. 5th ed. Volume 4 International Agency for Research on Cancer (IARC); Lyon, France: 2020. Female Genital Tumours.
    1. Brancaccio R.N., Robitaille A., Dutta S., Cuenin C., Santare D., Skenders G., Gheit T. Generation of a novel next-generation sequencing-based method for the isolation of new human papillomavirus types. Virology. 2018;520:1–10. doi: 10.1016/j.virol.2018.04.017. - DOI - PMC - PubMed
    1. Halec G., Schmitt M., Dondog B., Sharkhuu E., Wentzensen N., Gheit T., Pawlita M. Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int. J. Cancer. 2013;132:63–71. doi: 10.1002/ijc.27605. - DOI - PubMed
    1. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Cogliano V. A review of human carcinogens–Part B: Biological agents. Lancet Oncol. 2009;10:321–322. doi: 10.1016/S1470-2045(09)70096-8. - DOI - PubMed
    1. Haedicke J., Iftner T. Human papillomaviruses and cancer. Radiother. Oncol. 2013;108:397–402. doi: 10.1016/j.radonc.2013.06.004. - DOI - PubMed

LinkOut - more resources